Determination of Rebamipide in Human Plasma by HPLC

References

• Arakawa , T. , Watanabe , T. , Fukuda , T. , Yamasaki , K. and Kobayashi , K. 1995 . Rebamipide, a novel prostaglandin‐inducer, accelerates healing and reduces relapse of acetic acid‐induced rat gastric ulcer comparison with cimetidine . Dig. Dis. Sci. , 40 : 2469 – 2472 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Takemoto , T. 1989 . Clinical evaluation of proamipide (OPC‐12759) in gastric ulcer: a multicenter double‐blind comparison study with cetraxate . J. Adult. Dis. , 19 : 127 – 153 . [CSA]
   Google Scholar
• Ishihara , K. , Komura , Y. , Nishiyama , N. , Yamasaki , K. and Hotta , K. 1992 . Effect of rebamipide on mucus secretion by endogenous prostaglandin‐independent mechanism in rat gastric mucosa . Arzneim‐Forsch/Drug. Res. , 42 : 1462 – 1466 . [CSA]
   PubMed Web of Science ®Google Scholar
• Yamasaki , K. , Kanbe , T. , Chijiwa , T. , Ishiyama , H. and Morita , S. 1987 . Gastric mucosal protection by OPC‐12759, a novel antiulcer agent, in the rat . Eur. J. Pharmacol. , 142 : 23 – 29 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Murakami , K. , Okajima , K. , Uchiba , M. , Harada , N. , Johno , M. , Okabe , H. and Takatsuki , K. 1997 . Rebamipide attenuates indomethacin induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats . Dig. Dis. Sci. , 42 : 319 – 325 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Aihara , M. , Azuma , A. , Takizawa , H. , Tsuchimoto , D. , Funakoshi , Y. , Shindo , Y. , Ohmoto , Y. , Imagawa , K. , Kikuchi , M. , Mukaida , N. and Matsushita , K. 1998 . Molecular analysis of suppression of interleukin‐8 production by rebamipide in Helicobater pylori stimulated gastric cancer cell lines . Dig. Dis. Sci. , 43 : 174S – 180S . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Yoshikawa , T. , Naito , Y. and Kondo , M. 1993 . Free radical scavenging activity of the novel anti‐ulcer agent rebamipide studied by electron spin resonance . Arzneim‐Forsch/Drug. Res. , 43 : 363 – 366 . [CSA]
   PubMed Web of Science ®Google Scholar
• Yoshihide , S. and Takefumi , S. 1988 . High performance liquid chromatographic procedure for the determination of a new anti‐gastric ulcer agent, 2‐(4‐chlorobenzoylamino)‐3‐[2(1H)‐quinolinon‐4‐yl]propionic acid, in human plasma and urine . J. Chromatogr. , 434 : 283 – 287 .
   PubMed Web of Science ®Google Scholar
• Zhao , R. , Duan , J. and Yan , B. 1999 . Determination of rebamipide in plasma by HPLC and its pharmacokinetic study . Zhongguo Yaoxue Zazhi. , 34 : 369 – 399 .
   Google Scholar
• Zu , L. , Li , L. and Yu , D. 2002 . Determination of rebamipide in plasma by high performance liquid chromatography . Zhongguo Yiyuan Yaoxue Zazhi. , 22 : 353 – 355 .
   Google Scholar
• Xu , H. , Zhou , Y. and Fu , Y. 2001 . RP‐HPLC determination of rebamipide in tablets . Yaowu Fenxi Zazhi. , 21 : 362 – 363 .
   Google Scholar
• Cho , H. Y. , Jeong , H. C. , Oh , I. , Moon , J. D. and Lee , Y. B. 2001 . Bioequivalence of rebamipide tablet to mucosta tablet (rebamipide 100 mg) . J. Kor. Pharm. Sci. , 31 ( 4 ) : 281 – 287 .
   Google Scholar
• Metzler , C. M. and Weiner , D. L. 1992 . Lexington PCNONLIN, SCI Software
   Google Scholar